Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 30-Nov-22 4:40 PM View:  | Keros Therapeutics, Inc. (KROS) | 29-Nov-22 | Exercise (in-the money or at-the-money) Duplicate | 7,176 | $0.00 | $0.72 | (< 1%) 4.64M to 4.63M | |
| 25-Oct-22 4:57 PM View: | Urogen Pharma Ltd. (URGN) | 21-Oct-22 | Option Exercise | 47,999 | $5.94 | $285,114.00 | 3% 1.43M to 1.48M | |
| 28-Feb-23 12:21 PM View: | Urogen Pharma Ltd. (URGN) | 16-Jun-22 | Option Exercise | 2,211 | $5.00 | $11,055.00 | < 1% 1.43M to 1.44M | |
| 25-Aug-22 3:25 PM View: | Urogen Pharma Ltd. (URGN) | 06-Jun-22 | Option Exercise | 1,030 | $5.00 | $5,150.00 | < 1% 1.43M to 1.43M | |
| 17-May-21 7:02 AM View: | Senesco Technologies Inc. (ELOX) | 13-May-21 | Private Purchase | 5,925,920 | $1.35 | $8,000,000.00 | 63% 9.34M to 15.27M | |
| 09-Jun-21 1:42 PM View: | Urogen Pharma Ltd. (URGN) | 25-Mar-21 | Option Exercise | 2,211 | $5.00 | $11,055.00 | < 1% 1.43M to 1.43M | |
| 22-Apr-21 5:18 PM View: | Urogen Pharma Ltd. (URGN) | 24-Mar-21 | Option Exercise | 1,030 | $5.00 | $5,150.00 | < 1% 1.46M to 1.47M | |
| 26-Jan-21 5:07 PM View: | Prevail Therapeutics Inc. (PRVL) | 22-Jan-21 | Disposition (change in control) | 1,576,880 | -- | -- | (100%) 1.58M to 0 | |
| 19-Nov-20 4:40 PM View: | Keros Therapeutics, Inc. (KROS) | 17-Nov-20 | Purchase Duplicate | 60,000 | $50.00 | $3,000,000.00 | 1% 4.73M to 4.79M | |
| 13-Apr-20 5:16 PM View: | Keros Therapeutics, Inc. (KROS) | 13-Apr-20 | Conversion Duplicate | 3,545,100 | -- | -- | 471% 751.91K to 4.3M | |
| 13-Apr-20 5:16 PM View: | Keros Therapeutics, Inc. (KROS) | 13-Apr-20 | Purchase Duplicate | 437,499 | $16.00 | $6,999,980.00 | 10% 4.3M to 4.73M | |
| 16-Jan-20 3:57 PM View: | ArQule Inc. (ARQL) | 16-Jan-20 | Disposition (change in control) | 8,744,820 | $20.00 | $174,896,000.00 | (100%) 8.74M to 0 | |
| 27-Dec-19 8:48 PM View: | ArQule Inc. (ARQL) | 24-Dec-19 | Payment of Exercise | 145,301 | $20.11 | $2,922,000.00 | (2%) 8.89M to 8.74M | |
| 27-Dec-19 8:48 PM View: | ArQule Inc. (ARQL) | 24-Dec-19 | Option Exercise | 1,669,710 | $1.75 | $2,922,000.00 | 23% 7.22M to 8.89M | |
| 16-Sep-19 4:42 PM View: | ArQule Inc. (ARQL) | 12-Sep-19 | Exercise (in-the money or at-the-money) | 114,286 | $1.75 | $200,000.00 | 2% 7.11M to 7.22M | |
| 01-Jul-19 11:50 AM View: | ArQule Inc. (ARQL) | 27-Jun-19 | Purchase | 307,692 | $9.75 | $3,000,000.00 | 5% 6.8M to 7.11M | |
| 26-Jun-19 4:51 PM View: | Senesco Technologies Inc. (ELOX) | 24-Jun-19 | Market Purchase Duplicate | 200,000 | $9.00 | $1,800,000.00 | 2% 9.14M to 9.34M | 10% |
| 22-Oct-18 2:54 PM View: | ArQule Inc. (ARQL) | 13-Jul-18 | Market Purchase | 181,818 | $5.50 | $999,999.00 | 3% 6.62M to 6.8M | (38%) |
| 18-May-18 5:41 PM View: | ArQule Inc. (ARQL) | 18-May-18 | Market Purchase | 8,611 | $3.29 | $28,330.20 | 100% 0 to 8.61K | 4% |
| 25-May-18 4:30 PM View: | ArQule Inc. (ARQL) | 08-May-18 | Acquisition (other) | 6,608,000 | -- | -- | 100% 0 to 6.61M | |
| 01-May-18 4:34 PM View: | Senesco Technologies Inc. (ELOX) | 30-Apr-18 | Private Purchase Duplicate | 350,000 | $9.75 | $3,412,500.00 | 4% 8.79M to 9.14M | |
| 23-Mar-18 4:20 PM View: | Senesco Technologies Inc. (ELOX) | 22-Mar-18 | Market Purchase Duplicate | 6,000 | $8.00 | $48,000.00 | < 1% 8.78M to 8.79M | 28% |
| 23-Mar-18 4:20 PM View: | Senesco Technologies Inc. (ELOX) | 21-Mar-18 | Market Purchase Duplicate | 6,600 | $7.55 | $49,830.00 | < 1% 8.78M to 8.78M | 30% |
| 05-Oct-17 8:26 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 4,360 | -- | -- | (31%) 14.19K to 9.83K | |
| 05-Oct-17 8:26 PM View: | Kite Pharma, Inc. (KITE) | 03-Oct-17 | Disposition | 9,832 | -- | -- | (100%) 9.83K to 0 | |
| 22-Jun-17 2:37 PM View: | Kite Pharma, Inc. (KITE) | 20-Jun-17 | Grant | 2,410 | -- | -- | 20% 11.78K to 14.19K | |
| 11-May-17 2:02 PM View: | Kite Pharma, Inc. (KITE) | 09-May-17 | Market Purchase | 9,832 | $69.11 | $679,474.00 | 504% 1.95K to 11.78K | 160% |
| 03-Jun-16 7:13 PM View: | Kite Pharma, Inc. (KITE) | 01-Jun-16 | Grant | 1,950 | -- | -- | 100% 0 to 1.95K | |
| 03-Jun-15 7:40 PM View: | Kite Pharma, Inc. (KITE) | 02-Jun-15 | Market Sale (Planned) | 224,674 | $55.36 | $12,437,200.00 | (100%) 224.67K to 0 | (217%) |
| 03-Jun-15 7:40 PM View: | Kite Pharma, Inc. (KITE) | 01-Jun-15 | Market Sale (Planned) | 80,760 | $55.34 | $4,469,230.00 | (26%) 305.43K to 224.67K | (218%) |
| 31-Mar-15 8:38 PM View: | Kite Pharma, Inc. (KITE) | 30-Mar-15 | Market Sale | 115,857 | $59.91 | $6,941,470.00 | (28%) 421.29K to 305.43K | (193%) |
| 31-Mar-15 8:38 PM View: | Kite Pharma, Inc. (KITE) | 27-Mar-15 | Market Sale | 77,873 | $61.24 | $4,769,020.00 | (16%) 500.0K to 422.13K | (187%) |
| 27-Jun-14 5:50 PM View: | Kite Pharma, Inc. (KITE) | 25-Jun-14 | Conversion | 2,201,940 | -- | -- | 100% 0 to 2.2M |